Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model
Open Access
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Novo Nordisk Fonden
This publication has 35 references indexed in Scilit:
- Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary reportCardiovascular Diabetology, 2020
- Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19International Journal of Molecular Sciences, 2020
- Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and ErythrocytesInternational Journal of Molecular Sciences, 2020
- High-throughput microfluidic imaging flow cytometryCurrent Opinion in Biotechnology, 2019
- Diagnostic Potential of Imaging Flow CytometryTrends in Biotechnology, 2018
- Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stainsJournal of The Royal Society Interface, 2018
- Flow Cytometry: An OverviewCurrent Protocols in Immunology, 2018
- An open-source solution for advanced imaging flow cytometry data analysis using machine learningMethods, 2017
- A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to DiseaseJournal of Alzheimer’s Disease, 2016
- Flow cytometry and cell sorting of heterogeneous microbial populations: The importance of single-cell analyses1996